These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17171571)

  • 1. High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.
    Gibcus JH; Kok K; Menkema L; Hermsen MA; Mastik M; Kluin PM; van der Wal JE; Schuuring E
    Hum Genet; 2007 Apr; 121(2):187-201. PubMed ID: 17171571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
    Gibcus JH; Menkema L; Mastik MF; Hermsen MA; de Bock GH; van Velthuysen ML; Takes RP; Kok K; Alvarez Marcos CA; van der Laan BF; van den Brekel MW; Langendijk JA; Kluin PM; van der Wal JE; Schuuring E
    Clin Cancer Res; 2007 Nov; 13(21):6257-66. PubMed ID: 17975136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
    Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
    Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.
    Huang X; Gollin SM; Raja S; Godfrey TE
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11369-74. PubMed ID: 12172009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
    Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
    Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1, EMS1 and 11q13 amplification in breast cancer.
    Ormandy CJ; Musgrove EA; Hui R; Daly RJ; Sutherland RL
    Breast Cancer Res Treat; 2003 Apr; 78(3):323-35. PubMed ID: 12755491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review.
    Schuuring E
    Gene; 1995 Jun; 159(1):83-96. PubMed ID: 7607576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of 11q13 in ovarian carcinoma.
    Brown LA; Kalloger SE; Miller MA; Shih IeM; McKinney SE; Santos JL; Swenerton K; Spellman PT; Gray J; Gilks CB; Huntsman DG
    Genes Chromosomes Cancer; 2008 Jun; 47(6):481-9. PubMed ID: 18314909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma.
    Huang X; Godfrey TE; Gooding WE; McCarty KS; Gollin SM
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1058-69. PubMed ID: 16906560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
    J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
    Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
    Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
    Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
    Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.
    Lázár V; Ecsedi S; Szöllosi AG; Tóth R; Vízkeleti L; Rákosy Z; Bégány A; Adány R; Balázs M
    Mod Pathol; 2009 Oct; 22(10):1367-78. PubMed ID: 19633643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
    Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
    Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.